Álvarez-Vallina L - Search Results

1

Efficient preclinical treatment of cortical T cell acute lymphoblastic leukemia with T lymphocytes secreting anti-CD1a T cell engagers.

Jiménez-Reinoso A, Tirado N, Martinez-Moreno A, Díaz VM, García-Peydró M, Hangiu O, Díez-Alonso L, Albitre Á, Penela P, Toribio ML, Menéndez P, Álvarez-Vallina L, Sánchez Martínez D. Jiménez-Reinoso A, et al. Among authors: alvarez vallina l. J Immunother Cancer. 2022 Dec;10(12):e005333. doi: 10.1136/jitc-2022-005333. J Immunother Cancer. 2022. PMID: 36564128 Free PMC article.

2

Generation and characterization of monospecific and bispecific hexavalent trimerbodies.

Blanco-Toribio A, Sainz-Pastor N, Álvarez-Cienfuegos A, Merino N, Cuesta ÁM, Sánchez-Martín D, Bonet J, Santos-Valle P, Sanz L, Oliva B, Blanco FJ, Álvarez-Vallina L. Blanco-Toribio A, et al. MAbs. 2013 Jan-Feb;5(1):70-9. doi: 10.4161/mabs.22698. Epub 2012 Dec 5. MAbs. 2013. PMID: 23221741 Free PMC article.

3

Functionally fused antibodies--a novel adjuvant fusion system.

Larsen M, Jensen KB, Christensen PA, Suarez E, Paris D, Sanz L, Ravn P, Sauce D, Saas P, Goletz S, Alvarez-Vallina L, Kristensen P. Larsen M, et al. J Immunol Methods. 2008 Dec 31;339(2):220-7. doi: 10.1016/j.jim.2008.09.015. Epub 2008 Oct 12. J Immunol Methods. 2008. PMID: 18854189

4

Delay in resumption of the activity of tetracycline-regulatable promoter following removal of tetracycline analogues.

A-Mohammadi S, Alvarez-Vallina L, Ashworth LJ, Hawkins RE. A-Mohammadi S, et al. Gene Ther. 1997 Sep;4(9):993-7. doi: 10.1038/sj.gt.3300491. Gene Ther. 1997. PMID: 9349437

5

Pharmacological control of antigen responsiveness in genetically modified T lymphocytes.

Alvarez-Vallina L, Agha-Mohammadi S, Hawkins RE, Russell SJ. Alvarez-Vallina L, et al. J Immunol. 1997 Dec 15;159(12):5889-95. J Immunol. 1997. PMID: 9550385

6

The extracellular matrix: a new turn-of-the-screw for anti-angiogenic strategies.

Sanz L, Alvarez-Vallina L. Sanz L, et al. Trends Mol Med. 2003 Jun;9(6):256-62. doi: 10.1016/s1471-4914(03)00070-4. Trends Mol Med. 2003. PMID: 12829014

7

Antibodies and gene therapy: teaching old 'magic bullets' new tricks.

Sanz L, Blanco B, Alvarez-Vallina L. Sanz L, et al. Trends Immunol. 2004 Feb;25(2):85-91. doi: 10.1016/j.it.2003.12.001. Trends Immunol. 2004. PMID: 15102367 Review.

8

Improved stability of multivalent antibodies containing the human collagen XV trimerization domain.

Cuesta AM, Sánchez-Martín D, Blanco-Toribio A, Villate M, Enciso-Álvarez K, Alvarez-Cienfuegos A, Sainz-Pastor N, Sanz L, Blanco FJ, Alvarez-Vallina L. Cuesta AM, et al. MAbs. 2012 Mar-Apr;4(2):226-32. doi: 10.4161/mabs.4.2.19140. Epub 2012 Mar 1. MAbs. 2012. PMID: 22453098 Free PMC article.

9

Antigen-specific targeting of CD28-mediated T cell co-stimulation using chimeric single-chain antibody variable fragment-CD28 receptors.

Alvarez-Vallina L, Hawkins RE. Alvarez-Vallina L, et al. Eur J Immunol. 1996 Oct;26(10):2304-9. doi: 10.1002/eji.1830261006. Eur J Immunol. 1996. PMID: 8898938

10

Functional improvement of antibody fragments using a novel phage coat protein III fusion system.

Jensen KB, Larsen M, Pedersen JS, Christensen PA, Alvarez-Vallina L, Goletz S, Clark BF, Kristensen P. Jensen KB, et al. Biochem Biophys Res Commun. 2002 Nov 8;298(4):566-73. doi: 10.1016/s0006-291x(02)02484-1. Biochem Biophys Res Commun. 2002. PMID: 12408989

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

109 results

Search Page